Planned in cooperation with the Hematology/Oncology Pharmacy Association and the American College of Clinical Pharmacy
3.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Casey B. Williams, PharmD, BCOP, Hematology/Oncology Clinical Coordinator and Residency Director, University of Kansas Hospital, Kansas City; and Chair, HOPA/BCOP Recertification Committee, Hematology/Oncology Pharmacy Association

Please note: If you are attending this program for BCOP recertification, there are different instructions for claiming CE from those attending only for ACPE credit.

ACPE Credit Only: Instructions for claiming CE will be available in the session room. CE will be provided by the Hematology/Oncology Pharmacy Association (HOPA).

BCOP Recertification: These sessions are part of the professional development program for recertification of Board Certified Oncology Pharmacists (BCOPs), approved by the Board of Pharmaceutical Specialties (BPS). Part I will be presented on Tuesday, December 8, 8:00 a.m. — 11:00 a.m. BCOPs must attend all six hours of programming to be eligible to complete the Web-based post-test for oncology recertification credit. Partial credit is not available for recertification, but is available for ACPE credit.

In the session room, you must complete a paper registration form and swipe your Electronic Business Card (received at Registration) in the card reader provided in the session room. You must swipe your Electronic Business Card in both the morning and afternoon session as you enter and exit the session room.

The post-test fee is $45. After the Midyear Clinical Meeting, program participants will receive email instructions to purchase and access the test, as well as claim ACPE credit. The post-test examination must be completed and submitted by December 31, 2009.

2:00 p.m. — 3:00 p.m.
Update on Sarcomas: Soft Tissue, Osteosarcoma, Ewing's Sarcoma and GIST
ACPE Activity# 465-000-09-007-L01-P - 1.0 Contact Hour
Presenter: Dawn Goetz, PharmD, BCOP, Clinical Pharmacist, Medical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL

Learning Objectives:

• Review the management of soft tissue sarcoma (STS), osteosarcoma (OGS), Ewing's sarcoma, and gastrointestinal stromal tumors (GIST).


• Discuss the role of adjuvant chemotherapy for resected STS.


• Describe current treatment strategies for advanced/metastatic STS, OGS, Ewing's, and GIST.

3:00 p.m. — 4:00 p.m.
Current Statistical Considerations in Oncology Practice
ACPE Activity# 465-000-09-006-L01-P - 1.0 Contact Hour
Presenter: Kristine Crews, PharmD, BCPS, Translational Research Laboratory Director, St. Jude Children's Research Hospital, Memphis, TN

Learning Objectives:

• List three examples of clinical endpoints that may be measured and reported in oncology clinical trials.


• Describe the appropriate incorporation of biomarkers into the design of clinical trials.


• Discuss the proper use of non-inferiority trials in oncology research.

4:00 p.m. — 5:00 p.m.
Acute Lymphoblastic Leukemia: An Update
ACPE Activity# 465-000-09-010-L01-P - 1.0 Contact Hour
Presenter: Laura E.Wiggins, PharmD, BCOP, Clinical Pharmacist, BMT and Leukemia Service, Shands Hospital at the University of Florida, Gainsville

Learning Objectives:

• Compare and contrast adult and pediatric acute lymphoblastic leukemia (ALL).


• Review the results of MRC E2993.


• Discuss the roles of imatinib and nelarabine in treating ALL.


• Discus certain drug specific issues.